Revolutionizing type 2 diabetes treatment: personalized approach shows promise in matching patients with optimal glucose-lowering therapies

FHS
August 10, 2023
10:37 am

A personalized therapy selection algorithm for two diabetes type 2 (T2D) treatment drug classes.

Ovid asks USPTO to review Marinus’ patent around treatment of serious seizure condition

Ovid Therapeutics is ramping up its patent fight with Marinus Pharmaceuticals. The rival biotechs have been battling for more than a year over patent claims

March 28, 2024

Neutrophils: Unraveling their multifaceted roles in inflammatory bowel disease and gut microbiota interactions

Research delves into the complex roles of neutrophils in inflammatory bowel disease (IBD), exploring their diverse functions and interactions with the gut microbiota and emphasizing

December 28, 2023

AMA Delegates Take Action on Cannabis, Medical Aid-in-Dying Resolutions

NATIONAL HARBOR, Md. — The American Medical Association (AMA) should work to educate physicians and the public on the health risks of cannabis to children

November 15, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.